Bendamustine plus mitoxantrone for relapsed/refractory chronic lymphocytic leukaemia (CLL): results of a multicentre phase II study of the German CLL Study Group (GCLLSG)-Reference-Cited by-同舟云学术

Bendamustine plus mitoxantrone for relapsed/refractory chronic lymphocytic leukaemia (CLL): results of a multicentre phase II study of the German CLL Study Group (GCLLSG)

Published:2012-05-10 Issue:2 Volume:158 Page:238-241
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Köppler Hubert¹,Fuss Harald²,Hurtz Hans J.³,Knigge Owe⁴,Losem Christoph⁵,Reschke Daniel⁶,Schmitz Stephan⁷,Weide Rudolf¹,Weiß Johann⁸,Hallek Michael⁹,

Affiliation:

1. Haematology/Oncology Group Practice; Koblenz Germany

2. Department of Internal Medicine III HELIOS Klinikum; Bad Saarow Germany

3. Haematology/Oncology Group Practice; Halle Germany

4. Department of Haematology/Oncology Klinikum; Frankfurt/Oder Germany

5. Haematology/Oncology Group Practice; Neuss Germany

6. Haematology/Oncology Group Practice; Oldenburg Germany

7. Haematology/Oncology Group Practice; Köln Germany

8. Haematology/Oncology Practice; Weiden Germany

9. Department I of Internal Medicine; Centre for Integrated Oncology (CIO) Köln-Bonn; University of Cologne; Cologne Germany

Funder

Mundipharma GmbH

Ribosepharm GmbH

Lederle

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2012.09132.x/fullpdf

Reference15 articles.

1. Sample size tables for exact single-stage phase II designs;A'Hern;Statistics in Medicine,2001

2. Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL;Badoux;Blood,2011

3. Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group;Bergmann;Haematologica,2005

4. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas;Bremer;Journal of Cancer Research Clincal Oncology,2002

5. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment;Cheson;Blood,1996

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective review;Therapeutic Advances in Hematology;2017-03-30

2. Cytotoxic and apoptosis-inducing effects of bendamustine used alone and in combination with rituximab on chronic lymphocytic leukemia cells in vitro;Postępy Higieny i Medycyny Doświadczalnej;2014-12-05

3. ‘Use it again!’: retherapy with bendamustine in indolent B-cell lymphoproliferative disorders;Expert Review of Hematology;2013-06

4. Retreatment with bendamustine-containing regimens in patients with relapsed/refractory chronic lymphocytic leukemia and indolent B-cell lymphomas achieves high response rates and some long lasting remissions;Leukemia & Lymphoma;2012-12-05

5. Stratégies classiques de traitement des rechutes de leucémie lymphoïde chronique;Bulletin du Cancer;2012-12